Soo Joo Lee Selected Research

Soo Joo Lee Research Topics

Disease

49	Stroke (Strokes) 05/2024 - 12/2006
40	Ischemic Stroke 05/2024 - 07/2002
9	Atrial Fibrillation 02/2024 - 12/2014
8	Atherosclerosis 03/2024 - 01/2016
5	Myocardial Infarction 05/2024 - 01/2019
5	Infarction (Infarctions) 11/2021 - 07/2002
4	Hypertension (High Blood Pressure) 02/2023 - 01/2016
4	Hemorrhage 01/2023 - 01/2011
4	Brain Ischemia (Cerebral Ischemia) 07/2021 - 11/2010
2	Hemorrhagic Stroke 01/2023 - 01/2016
2	Cognitive Dysfunction 01/2023 - 01/2020
2	Hyperlipidemias (Hyperlipidemia) 01/2022 - 12/2014
2	Transient Ischemic Attack 01/2022 - 01/2019
2	Embolic Stroke 11/2021 - 12/2020
2	Pathologic Constriction (Stenosis) 01/2020 - 11/2019
2	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 12/2006
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 06/2019 - 09/2016
2	Ischemia 11/2010 - 03/2003
1	Hyperglycemia 02/2023
1	Hypothermia 02/2023
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Neoplasms (Cancer) 01/2022
1	Headache (Headaches) 01/2022
1	Migraine Disorders (Migraine) 01/2022
1	Blood Vessel Dissection 01/2022
1	Thrombosis (Thrombus) 11/2021
1	Intracranial Thrombosis (Cerebral Thrombosis) 11/2021
1	Cerebral Infarction 11/2021
1	Frailty 12/2020
1	Leukocytosis (Pleocytosis) 10/2020
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2020
1	Chronic Renal Insufficiency 06/2018
1	Myocardial Ischemia (Ischemic Heart Diseases) 06/2018
1	Neurologic Manifestations (Neurological Manifestations) 06/2017
1	Cerebral Hemorrhage 10/2016
1	Intracranial Arteriosclerosis (Cerebral Atherosclerosis) 01/2016
1	Diabetes Mellitus 12/2014
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 05/2014
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2006

Drug/Important Bio-Agent (IBA)

13	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2024 - 01/2011
9	Clopidogrel (Plavix)FDA Link 05/2024 - 01/2016
8	Tissue Plasminogen Activator (Alteplase)FDA Link 06/2019 - 11/2010
7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2023 - 05/2015
4	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 05/2024 - 11/2019
3	AnticoagulantsIBA 02/2024 - 12/2020
3	LDL CholesterolIBA 11/2023 - 01/2023
3	oxidized low density lipoproteinIBA 09/2023 - 09/2022
3	Glucose (Dextrose)FDA LinkGeneric 02/2023 - 10/2020
3	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2023 - 01/2011
2	Cilostazol (Pletal)FDA LinkGeneric 01/2022 - 01/2011
2	Antihypertensive Agents (Antihypertensives)IBA 07/2021 - 05/2015
2	Calcibiotic Root Canal SealerIBA 01/2021 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 09/2020 - 05/2020
2	Proteins (Proteins, Gene)FDA Link 09/2020 - 05/2020
2	Cholinergic Agents (Cholinergics)IBA 01/2020 - 12/2006
1	LDL Lipoproteins (beta Lipoproteins)IBA 03/2024
1	LipidsIBA 09/2023
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2023
1	oxiracetamIBA 01/2023
1	omega-Chloroacetophenone (Mace)IBA 10/2022
1	Dipyridamole (Persantine)FDA LinkGeneric 01/2022
1	Hemostatics (Antihemorrhagics)IBA 01/2022
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 10/2021
1	fimasartanIBA 07/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	A-factor (Streptomyces)IBA 10/2020
1	Hemoglobins (Hemoglobin)IBA 01/2020
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2020
1	Digoxin (Digitek)FDA LinkGeneric 06/2018
1	HDL CholesterolIBA 01/2016
1	Ethanol (Ethyl Alcohol)IBA 12/2015
1	CholesterolIBA 12/2014
1	Glycogen Synthase Kinase 3 betaIBA 12/2006
1	Glycogen Synthase KinasesIBA 12/2006
1	thiamine triphosphorate (TTP)IBA 03/2003

Therapy/Procedure

25	Therapeutics 05/2024 - 11/2010
7	Thrombectomy 02/2024 - 01/2017
5	Thrombolytic Therapy 06/2017 - 07/2002
4	Secondary Prevention 05/2024 - 01/2022
1	Ambulatory Care (Outpatient Care) 01/2021
1	Punctures 01/2021
1	Treatment Delay 05/2016
1	Drug Therapy (Chemotherapy) 01/2016